{"transactions":[{"id":4637622,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":23621,"kind":"person","name":"Wagner Heidi L","position":1,"cik":"0001655029","reported_name":"Wagner Heidi L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-10-08T01:00:05.000Z","date":"2026-10-05","kind":"grant","planned":false,"acquired":true,"shares":64000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person was granted this option pursuant to the 2026 Non-Employee Director Compensation Policy. The option vests as to 100% of the shares on the earlier of the Company's 2027 annual meeting of stockholders or October 5, 2027."}],"balance_after":64000,"derivative":{"exercise_price":3.75,"expiration_date":"2036-10-05","underlying":"Common Stock","underlying_shares":64000},"source":{"system":"sec-edgar","filing":"0001193125-26-417231","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1655029/000119312526417231/ownership.xml","form_type":"4"}},{"id":4637621,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":23621,"kind":"person","name":"Wagner Heidi L","position":1,"cik":"0001655029","reported_name":"Wagner Heidi L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-08T01:00:05.000Z","date":"2026-10-05","kind":"grant","planned":false,"acquired":true,"shares":10700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was granted this restricted stock unit award (RSU) pursuant to the 2026 Non-Employee Director Compensation Policy. The RSU vests as to 100% of the shares on the earlier of the Company's 2027 annual meeting of stockholders or October 5, 2027."}],"balance_after":55630,"source":{"system":"sec-edgar","filing":"0001193125-26-417231","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1655029/000119312526417231/ownership.xml","form_type":"4"}},{"id":687693,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":23621,"kind":"person","name":"Wagner Heidi L","position":1,"cik":"0001655029","reported_name":"Wagner Heidi L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-08-14T01:00:10.000Z","date":"2026-08-11","kind":"exercise","planned":true,"acquired":false,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These stock options are fully vested."}],"balance_after":0,"derivative":{"exercise_price":5.97,"expiration_date":"2026-08-16","underlying":"Ordinary Shares","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001193125-26-349963","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000119312526349963/ownership.xml","form_type":"4"}},{"id":687692,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":23621,"kind":"person","name":"Wagner Heidi L","position":1,"cik":"0001655029","reported_name":"Wagner Heidi L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-14T01:00:10.000Z","date":"2026-08-11","kind":"sale","planned":true,"acquired":false,"shares":7000,"price":6.01,"value":42070.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026."}],"balance_after":44930,"source":{"system":"sec-edgar","filing":"0001193125-26-349963","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000119312526349963/ownership.xml","form_type":"4"}},{"id":687691,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":23621,"kind":"person","name":"Wagner Heidi L","position":1,"cik":"0001655029","reported_name":"Wagner Heidi L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-14T01:00:10.000Z","date":"2026-08-11","kind":"exercise","planned":true,"acquired":true,"shares":7000,"price":5.97,"value":41790.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026."}],"balance_after":51930,"source":{"system":"sec-edgar","filing":"0001193125-26-349963","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000119312526349963/ownership.xml","form_type":"4"}},{"id":974002,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":23621,"kind":"person","name":"Wagner Heidi L","position":1,"cik":"0001655029","reported_name":"Wagner Heidi L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2025-12-11T02:45:14.000Z","date":"2025-12-08","kind":"exercise","planned":true,"acquired":false,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These share options are fully vested."}],"balance_after":7000,"derivative":{"exercise_price":5.97,"expiration_date":"2026-08-16","underlying":"Ordinary Shares","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001193125-25-314741","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000119312525314741/ownership.xml","form_type":"4"}},{"id":974001,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":23621,"kind":"person","name":"Wagner Heidi L","position":1,"cik":"0001655029","reported_name":"Wagner Heidi L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-12-11T02:45:14.000Z","date":"2025-12-08","kind":"sale","planned":true,"acquired":false,"shares":7000,"price":14,"value":98000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2025."}],"balance_after":44930,"source":{"system":"sec-edgar","filing":"0001193125-25-314741","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000119312525314741/ownership.xml","form_type":"4"}},{"id":974000,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":23621,"kind":"person","name":"Wagner Heidi L","position":1,"cik":"0001655029","reported_name":"Wagner Heidi L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-12-11T02:45:14.000Z","date":"2025-12-08","kind":"exercise","planned":true,"acquired":true,"shares":7000,"price":5.97,"value":41790.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2025."}],"balance_after":51930,"source":{"system":"sec-edgar","filing":"0001193125-25-314741","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000119312525314741/ownership.xml","form_type":"4"}},{"id":973999,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":23621,"kind":"person","name":"Wagner Heidi L","position":1,"cik":"0001655029","reported_name":"Wagner Heidi L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-12-11T02:45:14.000Z","date":"2025-12-08","kind":"sale","planned":true,"acquired":false,"shares":7000,"price":13,"value":91000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2025."}],"balance_after":44930,"source":{"system":"sec-edgar","filing":"0001193125-25-314741","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000119312525314741/ownership.xml","form_type":"4"}},{"id":973998,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":23621,"kind":"person","name":"Wagner Heidi L","position":1,"cik":"0001655029","reported_name":"Wagner Heidi L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-12-11T02:45:14.000Z","date":"2025-12-08","kind":"exercise","planned":true,"acquired":true,"shares":7000,"price":5.97,"value":41790.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2025."}],"balance_after":51930,"source":{"system":"sec-edgar","filing":"0001193125-25-314741","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000119312525314741/ownership.xml","form_type":"4"}},{"id":1067503,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":23621,"kind":"person","name":"Wagner Heidi L","position":1,"cik":"0001655029","reported_name":"Wagner Heidi L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2025-08-14T00:00:10.000Z","date":"2025-08-11","kind":"grant","planned":false,"acquired":true,"shares":76200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person was granted this option pursuant to the 2025 Non-Employee Director Compensation Policy. The option vests as to 100% of the shares on the earlier of the Company's 2026 annual general meeting or August 11, 2026."}],"balance_after":76200,"derivative":{"exercise_price":8.105,"expiration_date":"2030-08-11","underlying":"Ordinary Shares","underlying_shares":76200},"source":{"system":"sec-edgar","filing":"0000950170-25-108288","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000095017025108288/ownership.xml","form_type":"4"}},{"id":1067502,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":23621,"kind":"person","name":"Wagner Heidi L","position":1,"cik":"0001655029","reported_name":"Wagner Heidi L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-14T00:00:10.000Z","date":"2025-08-11","kind":"grant","planned":false,"acquired":true,"shares":12700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was granted this restricted share unit award (RSU) pursuant to the 2025 Non-Employee Director Compensation Policy. The RSU vests as to 100% of the shares on the earlier of the Company's 2026 annual general meeting or August 11, 2026."}],"balance_after":44930,"source":{"system":"sec-edgar","filing":"0000950170-25-108288","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000095017025108288/ownership.xml","form_type":"4"}},{"id":1433330,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":23621,"kind":"person","name":"Wagner Heidi L","position":1,"cik":"0001655029","reported_name":"Wagner Heidi L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2024-08-14T22:00:04.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":64460,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person was granted this option pursuant to the 2024 Non-Employee Director Compensation Policy. The option vests as to 12.5% on a quarterly basis beginning August 12, 2024, through the two-year period following the grant date."}],"balance_after":64460,"derivative":{"exercise_price":5.37,"expiration_date":"2029-08-12","underlying":"Ordinary Shares","underlying_shares":64460},"source":{"system":"sec-edgar","filing":"0000950170-24-097284","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000095017024097284/ownership.xml","form_type":"4"}},{"id":1433329,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":23621,"kind":"person","name":"Wagner Heidi L","position":1,"cik":"0001655029","reported_name":"Wagner Heidi L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2024-08-14T22:00:04.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":32230,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was granted this restricted share unit award (RSU) pursuant to the 2024 Non-Employee Director Compensation Policy. The RSU vests as to 50% on each of (i) the earlier of the Company's 2025 annual general meeting or August 12, 2025; and (ii) the earlier of the Company's 2026 annual general meeting or August 12, 2026."}],"balance_after":32230,"source":{"system":"sec-edgar","filing":"0000950170-24-097284","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000095017024097284/ownership.xml","form_type":"4"}},{"id":1811684,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":23621,"kind":"person","name":"Wagner Heidi L","position":1,"cik":"0001655029","reported_name":"Wagner Heidi L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2023-08-10T00:00:24.000Z","date":"2023-08-07","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person was granted this option pursuant to the Non-Employee Director Compensation Policy. The option vests as to 100% of the shares on the earlier of the Company's 2024 annual general meeting or August 7, 2024."}],"balance_after":45000,"derivative":{"exercise_price":4.58,"expiration_date":"2028-08-07","underlying":"Ordinary Shares","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0000899243-23-017914","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000089924323017914/doc4.xml","form_type":"4"}},{"id":2180641,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":23621,"kind":"person","name":"Wagner Heidi L","position":1,"cik":"0001655029","reported_name":"Wagner Heidi L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2022-08-18T00:01:01.000Z","date":"2022-08-15","kind":"grant","acquired":true,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person was granted this option pursuant to the Non-Employee Director Compensation Policy. The option vests as to 100% of the shares on the earlier of the Company's 2023 annual general meeting or August 15, 2023."}],"balance_after":21000,"derivative":{"exercise_price":3.5,"expiration_date":"2027-08-15","underlying":"Ordinary Shares","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0000899243-22-029097","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000089924322029097/doc4.xml","form_type":"4"}},{"id":2597193,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":23621,"kind":"person","name":"Wagner Heidi L","position":1,"cik":"0001655029","reported_name":"Wagner Heidi L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2021-08-18T22:18:41.000Z","date":"2021-08-16","kind":"grant","acquired":true,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person was granted this option pursuant to the Non-Employee Director Compensation Policy. The option vests as to 100% of the shares on the earlier of the Company's 2022 annual general meeting or August 16, 2022."}],"balance_after":21000,"derivative":{"exercise_price":5.97,"expiration_date":"2026-08-16","underlying":"Ordinary Shares","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0000899243-21-033531","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000089924321033531/doc4.xml","form_type":"4"}},{"id":3050661,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":23621,"kind":"person","name":"Wagner Heidi L","position":1,"cik":"0001655029","reported_name":"Wagner Heidi L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2020-08-20T22:33:10.000Z","date":"2020-08-18","kind":"grant","acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person was granted this option pursuant to the Non-Employee Director Compensation Policy. The option vests as to 100% of the shares on the earlier of the Company's 2021 annual general meeting or August 18, 2021."}],"balance_after":10500,"derivative":{"exercise_price":9.13,"expiration_date":"2025-08-18","underlying":"Ordinary Shares","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0000899243-20-023088","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000089924320023088/doc4.xml","form_type":"4"}},{"id":3420312,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":23621,"kind":"person","name":"Wagner Heidi L","position":1,"cik":"0001655029","reported_name":"Wagner Heidi L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2019-09-06T22:46:35.000Z","date":"2019-09-04","kind":"grant","acquired":true,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person was granted this option pursuant to the Non-Employee Director Compensation Policy. The option vests as to 25% of the shares on September 4, 2020 and the remainder vests quarterly thereafter until September 4, 2023."}],"balance_after":21000,"derivative":{"exercise_price":21.03,"expiration_date":"2024-09-04","underlying":"Ordinary Shares","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0000899243-19-023034","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000089924319023034/doc4.xml","form_type":"4"}},{"id":4025206,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":23621,"kind":"person","name":"Wagner Heidi L","position":1,"cik":"0001655029","reported_name":"Wagner Heidi L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Global Government Affairs"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2018-03-01T17:25:00.000Z","date":"2018-02-28","kind":"sale","acquired":false,"shares":454,"price":118.61,"value":53848.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units."}],"balance_after":49140,"source":{"system":"sec-edgar","filing":"0000899866-18-000047","document":"wf-form4_151994308448663.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986618000047/wf-form4_151994308448663.xml","form_type":"4"}},{"id":4025205,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":23621,"kind":"person","name":"Wagner Heidi L","position":1,"cik":"0001655029","reported_name":"Wagner Heidi L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Global Government Affairs"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2018-03-01T17:25:00.000Z","date":"2018-02-27","kind":"sale","acquired":false,"shares":244,"price":120.72,"value":29455.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units."}],"balance_after":49594,"source":{"system":"sec-edgar","filing":"0000899866-18-000047","document":"wf-form4_151994308448663.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986618000047/wf-form4_151994308448663.xml","form_type":"4"}},{"id":4071054,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":23621,"kind":"person","name":"Wagner Heidi L","position":1,"cik":"0001655029","reported_name":"Wagner Heidi L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Global Government Affairs"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2018-02-08T19:17:33.000Z","date":"2018-02-08","kind":"sale","acquired":false,"shares":1774,"price":116.31,"value":206333.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Performance Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $116.00 - $116.99.  The price reported in this column reflects the weighted average sales price.  Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price."}],"balance_after":49838,"source":{"system":"sec-edgar","filing":"0000899866-18-000041","document":"wf-form4_151813543967661.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986618000041/wf-form4_151813543967661.xml","form_type":"4"}},{"id":4071053,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":23621,"kind":"person","name":"Wagner Heidi L","position":1,"cik":"0001655029","reported_name":"Wagner Heidi L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Global Government Affairs"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2018-02-08T19:17:33.000Z","date":"2018-02-06","kind":"grant","acquired":true,"shares":4400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"On February 6, 2018, the Leadership and Compensation Committee determined that the reporting person earned 4,400 Performance Share Units upon achievement of certain performance targets previously established by the Committee. 1/4 of such shares vested on February 6, 2018 and 1/4 vest on each subsequent anniversary."}],"balance_after":51612,"source":{"system":"sec-edgar","filing":"0000899866-18-000041","document":"wf-form4_151813543967661.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986618000041/wf-form4_151813543967661.xml","form_type":"4"}},{"id":4071052,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":23621,"kind":"person","name":"Wagner Heidi L","position":1,"cik":"0001655029","reported_name":"Wagner Heidi L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Global Government Affairs"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2018-02-08T19:17:33.000Z","date":"2018-02-06","kind":"grant","acquired":true,"shares":14577,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 6, 2018, the Leadership and Compensation Committee determined that the reporting person earned 14,577 Performance Share Units upon achievement of certain performance targets previously established by the Committee. 1/3 of such shares vested on February 6, 2018 and 1/3 vest on each subsequent anniversary."}],"balance_after":47212,"source":{"system":"sec-edgar","filing":"0000899866-18-000041","document":"wf-form4_151813543967661.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986618000041/wf-form4_151813543967661.xml","form_type":"4"}},{"id":4072825,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":23621,"kind":"person","name":"Wagner Heidi L","position":1,"cik":"0001655029","reported_name":"Wagner Heidi L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Global Government Affairs"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2018-02-07T18:36:00.000Z","date":"2018-02-05","kind":"sale","acquired":false,"shares":655,"price":117.26,"value":76805.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units."}],"balance_after":32635,"source":{"system":"sec-edgar","filing":"0000899866-18-000016","document":"wf-form4_151804654651208.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986618000016/wf-form4_151804654651208.xml","form_type":"4"}},{"id":4192761,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":23621,"kind":"person","name":"Wagner Heidi L","position":1,"cik":"0001655029","reported_name":"Wagner Heidi L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Global Government Affairs"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2017-10-04T17:25:54.000Z","date":"2017-10-02","kind":"sale","acquired":false,"shares":120,"price":140,"value":16800.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units."}],"balance_after":33290,"source":{"system":"sec-edgar","filing":"0000899866-17-000170","document":"wf-form4_150715234025644.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986617000170/wf-form4_150715234025644.xml","form_type":"4"}},{"id":4415413,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":23621,"kind":"person","name":"Wagner Heidi L","position":1,"cik":"0001655029","reported_name":"Wagner Heidi L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Global Government Affairs"}}],"security":"Option to Purchase Common Stock","published_at":"2017-03-01T19:44:33.000Z","date":"2017-02-28","kind":"grant","acquired":true,"shares":8700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Stock option award under 2004 Incentive Plan.  25% vest on the first anniversary of the grant date, 1/16 every three months thereafter until fully vested over 4 years."}],"balance_after":8700,"derivative":{"exercise_price":131.25,"exercise_date":"2018-02-28","expiration_date":"2027-02-28","underlying":"Common Stock, par value $.0001 per share","underlying_shares":8700},"source":{"system":"sec-edgar","filing":"0000899866-17-000054","document":"wf-form4_148841545911470.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986617000054/wf-form4_148841545911470.xml","form_type":"4"}},{"id":4415412,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":23621,"kind":"person","name":"Wagner Heidi L","position":1,"cik":"0001655029","reported_name":"Wagner Heidi L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Global Government Affairs"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2017-03-01T19:44:33.000Z","date":"2017-02-28","kind":"grant","acquired":true,"shares":4400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Award of Restricted Stock Units under the 2004 Incentive Plan.  25% vests on each anniversary of the grant date."}],"balance_after":33410,"source":{"system":"sec-edgar","filing":"0000899866-17-000054","document":"wf-form4_148841545911470.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986617000054/wf-form4_148841545911470.xml","form_type":"4"}},{"id":4415411,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":23621,"kind":"person","name":"Wagner Heidi L","position":1,"cik":"0001655029","reported_name":"Wagner Heidi L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Global Government Affairs"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2017-03-01T19:44:33.000Z","date":"2017-03-01","kind":"sale","acquired":false,"shares":156,"price":132.5,"value":20670.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $132.00 - $132.99.  The price reported in this column reflects the weighted average sales price.  Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price."}],"balance_after":29010,"source":{"system":"sec-edgar","filing":"0000899866-17-000054","document":"wf-form4_148841545911470.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986617000054/wf-form4_148841545911470.xml","form_type":"4"}},{"id":4415410,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":23621,"kind":"person","name":"Wagner Heidi L","position":1,"cik":"0001655029","reported_name":"Wagner Heidi L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Global Government Affairs"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2017-03-01T19:44:33.000Z","date":"2017-02-28","kind":"sale","acquired":false,"shares":480,"price":131.7,"value":63216.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $131.00 - $131.99.  The price reported in this column reflects the weighted average sales price.  Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price."}],"balance_after":29166,"source":{"system":"sec-edgar","filing":"0000899866-17-000054","document":"wf-form4_148841545911470.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986617000054/wf-form4_148841545911470.xml","form_type":"4"}},{"id":4415409,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":23621,"kind":"person","name":"Wagner Heidi L","position":1,"cik":"0001655029","reported_name":"Wagner Heidi L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Global Government Affairs"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2017-03-01T19:44:33.000Z","date":"2017-02-27","kind":"sale","acquired":false,"shares":358,"price":131.2,"value":46969.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $131.00 - $131.99.  The price reported in this column reflects the weighted average sales price.  Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price."}],"balance_after":29646,"source":{"system":"sec-edgar","filing":"0000899866-17-000054","document":"wf-form4_148841545911470.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986617000054/wf-form4_148841545911470.xml","form_type":"4"}},{"id":4462464,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":23621,"kind":"person","name":"Wagner Heidi L","position":1,"cik":"0001655029","reported_name":"Wagner Heidi L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Global Government Affairs"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2017-02-08T16:38:54.000Z","date":"2017-02-07","kind":"sale","acquired":false,"shares":222,"price":128.09,"value":28435.98,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $128.00 - $128.99.  The price reported in this column reflects the weighted average sales price.  Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price."}],"balance_after":30004,"source":{"system":"sec-edgar","filing":"0000899866-17-000024","document":"wf-form4_148658992215835.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986617000024/wf-form4_148658992215835.xml","form_type":"4"}},{"id":4462463,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":23621,"kind":"person","name":"Wagner Heidi L","position":1,"cik":"0001655029","reported_name":"Wagner Heidi L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Global Government Affairs"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2017-02-08T16:38:54.000Z","date":"2017-02-06","kind":"sale","acquired":false,"shares":15,"price":126.04,"value":1890.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Performance Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $126.00 - $126.99.  The price reported in this column reflects the weighted average sales price.  Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price."}],"balance_after":30226,"source":{"system":"sec-edgar","filing":"0000899866-17-000024","document":"wf-form4_148658992215835.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986617000024/wf-form4_148658992215835.xml","form_type":"4"}},{"id":4462462,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":23621,"kind":"person","name":"Wagner Heidi L","position":1,"cik":"0001655029","reported_name":"Wagner Heidi L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Global Government Affairs"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2017-02-08T16:38:54.000Z","date":"2017-02-06","kind":"sale","acquired":false,"shares":1695,"price":125.69,"value":213044.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Performance Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $125.00 - $125.99.  The price reported in this column reflects the weighted average sales price.  Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price."}],"balance_after":30241,"source":{"system":"sec-edgar","filing":"0000899866-17-000024","document":"wf-form4_148658992215835.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986617000024/wf-form4_148658992215835.xml","form_type":"4"}},{"id":4553608,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":23621,"kind":"person","name":"Wagner Heidi L","position":1,"cik":"0001655029","reported_name":"Wagner Heidi L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Global Government Affairs"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2016-11-16T18:00:01.000Z","date":"2016-11-14","kind":"sale","acquired":false,"shares":59,"price":115.1,"value":6790.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units."}],"balance_after":31936,"source":{"system":"sec-edgar","filing":"0000899866-16-000383","document":"wf-form4_147933718744997.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986616000383/wf-form4_147933718744997.xml","form_type":"4"}},{"id":4585302,"issuer":{"id":137086,"kind":"organization","name":"ALEXION PHARMACEUTICALS, INC.","symbol":"ALXN"},"owners":[{"id":23621,"kind":"person","name":"Wagner Heidi L","position":1,"cik":"0001655029","reported_name":"Wagner Heidi L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Global Government Affairs"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2016-10-05T17:25:38.000Z","date":"2016-10-03","kind":"sale","acquired":false,"shares":120,"price":122.41,"value":14689.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging from $122.00 - $122.99.  The price reported in this column reflects the weighted average sales price.  Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price."}],"balance_after":31995,"source":{"system":"sec-edgar","filing":"0000899866-16-000364","document":"wf-form4_147570272539300.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899866/000089986616000364/wf-form4_147570272539300.xml","form_type":"4"}}]}